Each vial contains 200 g of lyophilized peptide derived from the human EP1 receptor sequence (C-terminal amino acids 380-402; GLTPSAWEASSLRSSRHSGLSHF. This peptide was used as an antigen for production of Cayman's EP1 receptor polyclonal antibody (Catalog No. 101740) and can be used in conjunction with this antibody to block protein-antibody complex formation during analysis for the EP1 receptor.

(Date:12/7/2016)... 7, 2016 Avanade is helping Williams ... teams in history, exploit biometric data in order to ... maintain the competitive edge against their rivals after their ... Avanade has worked with Williams during the 2016 ... data (heart rate, breathing rate, temperature and peak acceleration) ...

(Date:12/6/2016)... Valencell , the leading innovator in performance biometric ... consecutive year of triple digit growth for its PerformTek ... 360 percent increase in companies who have acquired Valencell ... sales of its wrist and ear Benchmark™ sensor systems, ... hearables for fitness and healthcare applications. ...

(Date:12/8/2016)... Dec. 8, 2016 Soligenix, Inc. (OTCQB: SNGX) ... on developing and commercializing products to treat rare diseases ... that it will be hosting an Investor Webcast Event ... the origins of innate defense regulators (IDRs) as a ... oral mucositis and the recently announced and published Phase ...